At a glance
ClinicalIndex Comparison RecordN/ACompleted· 110 enrolled
Drug / intervention
Clozapine +2 moredrug
Likely dose
Clozapine 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clozapine and Olanzapine in the Treatment of Violence in Schizophrenic Patients
Nathan Kline Institute for Psychiatric Research·interventional·Posted May 14, 2010·Updated May 14, 2010
In Brief
A clinical study evaluating Clozapine, Olanzapine, and 1 other intervention for Schizophrenia. Completed, enrolled 110 participants across 1 site.
Detailed Summary
This was a double-blind randomized study with three treatment arms: clozapine, olanzapine and haloperidol. We compared these three medications in the treatment of aggressive behavior over a 12 week period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 1999
Primary CompletionJul 2004
First PostedMay 2010
TodayJul 2026
First PostedMay 14, 2010
Enrollment StartJun 1, 1999
Primary CompletionJul 1, 2004
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 16.1 years ago
Interventions
Clozapinedrug
500 mg/day
Olanzapinedrug
20 mg/day
Haloperidoldrug
20 mg/day